Clinical Trials Logo

Clinical Trial Summary

Nasal microorganisms, exfoliated cells, nasal secretions, fetal microorganisms and blood were collected from patients with chronic sinusitis with nasal polyps before medication. Nasal polyp tissues of the patients were clamped for pathologic biopsy in the outpatient clinic. Methylprednisolone was then administered to the patients for 17 days, and the nasal microbial changes were observed after the administration of the drug. Patients underwent surgical treatment after the administration of the drug, and postoperative patients were followed up for a long period of time until polyp recurrence. During the follow-up, the microorganisms in the patients' postoperative nasal cavities were collected and the postoperative microbial changes were recorded


Clinical Trial Description

In this study, we retrospectively collected pathologic paraffin specimens and patient information from previous cases of sinusitis with nasal polyps, and prospectively collected specimens from newly enrolled patients with nasal polyps. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06231004
Study type Observational
Source The First Affiliated Hospital with Nanjing Medical University
Contact Lei Cheng, Phd
Phone 0086-13776620807
Email chenglei@jsph.org.cn
Status Not yet recruiting
Phase
Start date January 22, 2024
Completion date September 1, 2032

See also
  Status Clinical Trial Phase
Completed NCT03956862 - GB001 in Adult Participants With Chronic Rhinosinusitis Phase 2
Recruiting NCT06338995 - A Study of Lebrikizumab (LY3650150) in Adult Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP) Phase 3